The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

PM, Altria Group, Inc. MO and Turning Point Brands, Inc. TPB are investing heavily in reduced-risk products (RRPs) to capitalize on this growing trend.While cigarette sales continue to decline due to ...

Federal officials need to step up efforts to bar imported e-cigarettes that target youth with sweet flavors, a coalition of ...

The Office on Smoking and Health at the CDC is no more, putting state quitlines and national data on youth tobacco use at ...

The proposal would restrict sales of vape devices to those marketed in the U.S. as of 2016 and submitted for FDA ...

the Supreme Court handed down a ruling in a case involving flavored vapes sold by companies like Altria. The judges reversed an appeals court decision that the Food and Drug Administration (FDA ...

Altria Group ( MO -2.70%) stock was as popular as a used cigarette on Wednesday. The veteran tobacco company saw its share price wither by nearly 3% on the back of a U.S. Supreme Court ruling that ...

Investing.com -- Shares of Altria Group (NYSE:MO) dropped 4.5% following a U.S. Supreme Court decision largely in favor of the Food and Drug Administration’s rejection of applications for ...